When Is It Necessary to Repeat Key AML Tests?

https://vimeo.com/1195986327 Hematologist-oncologist Dr. Anand Patel explains why repeat testing is critical throughout AML care — from measuring the depth of remission with MRD testing to identifying new mutations if the…

Understanding MRD and Its Impact on AML Care

https://vimeo.com/1195986290 What is measurable residual disease (MRD), and why does it matter in AML care? Hematologist-oncologist Dr. Anand Patel explains how this advanced testing can detect tiny amounts of leukemia…

AML Treatment and Care Choices | The Role of Test Results

https://vimeo.com/1195986291 AML treatment options are expanding, giving patients more personalized approaches than ever before. AML specialist Dr. Anand Patel explains the differences between intensive chemotherapy and newer lower-intensity therapies, and…

Understanding AML Risk Categories and Why They Matter

https://vimeo.com/1195986292 What does it mean to have “favorable,” “intermediate,” or “adverse” risk AML, and how do those classifications affect treatment decisions? Hematologist-oncologist Dr. Anand Patel explains how in-depth test results…

Acute Myeloid Leukemia (AML): Which Tests Are Critical?

https://vimeo.com/1195986293 Understanding the purpose behind in-depth AML testing can help patients and care partners feel more informed and empowered. Hematologist-oncologist Dr. Anand Patel explains the key blood, bone marrow, molecular,…

INSIST! on Better Care: Why AML Testing Matters

https://vimeo.com/1191993605 How do test results impact AML treatment and care choices? AML specialist Dr. Anand Patel shares an overview of common AML testing, explains how results influence each step of…

Self-Advocacy | Why In-Depth Cancer Testing Is Essential

https://vimeo.com/1143931847 Dr. Heidi Gray explains why speaking up and asking about in-depth cancer testing can make a real difference in understanding your cancer care. With today’s rapidly evolving testing options…

When Should Someone With Cancer Undergo Molecular Testing?

https://vimeo.com/1133948722 Cancer researcher Dr. Paul Oberstein explains when patients should undergo molecular testing and why early testing can be crucial. Dr. Oberstein also discusses new methods like blood-based assays that…

Share On:

Facebook
Twitter
LinkedIn